Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

19.33
-0.7100-3.54%
Pre-market: 19.14-0.1880-0.97%06:20 EDT
Volume:575.98K
Turnover:11.24M
Market Cap:1.18B
PE:-11.77
High:20.23
Open:19.94
Low:19.27
Close:20.04
52wk High:35.34
52wk Low:12.12
Shares:61.14M
Float Shares:42.53M
Volume Ratio:0.48
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6429
EPS(LYR):-1.8336
ROE:-10.70%
ROA:-8.80%
PB:1.27
PE(LYR):-10.54

Loading ...

Janux Therapeutics Reports Results of 2026 Annual Meeting

TIPRANKS
·
Jun 13

Janux Therapeutics shareholders elect two directors at annual meeting

Reuters
·
Jun 13

Janux VP Accounting Maria Dobek sells 2,038 shares worth $28,874.46

Reuters
·
May 14

Janux Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
May 08

Wedbush Adjusts Janux Therapeutics Price Target to $36 From $45, Maintains Outperform Rating

MT Newswires Live
·
May 08

Janux Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
May 08

Guggenheim Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TIPRANKS
·
May 08

Janux Therapeutics price target lowered to $26 from $30 at Piper Sandler

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Janux Therapeutics Inc (JANX) and Progyny (PGNY)

TIPRANKS
·
May 08

Analyst Reiterates Buy on Janux, Citing Pipeline Upside and Key 2027 Catalyst; Price Target Maintained at $14

TIPRANKS
·
May 08

Janux Therapeutics: Strong Balance Sheet and Advancing PSMA Pipeline Underpin Buy Rating and Favorable Risk-Reward

TIPRANKS
·
May 08

Janux Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Janux Therapeutics Q1 EPS $(0.39) Beats $(0.53) Estimate, Sales $3.733M Miss $3.833M Estimate

Benzinga Earnings
·
May 08

Janux Q1 FY26 net loss widens to $24.4 million; R&D expenses rise to $26.8 million

Reuters
·
May 08

BRIEF-Janux Therapeutics Q1 Basic EPS USD -0.39

Reuters
·
May 08

Janux Therapeutics Q1 Net Income USD -24.361 Million

THOMSON REUTERS
·
May 08

Janux Therapeutics Q1 Operating Expenses USD 37.946 Million

THOMSON REUTERS
·
May 08

Guggenheim Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TIPRANKS
·
Apr 29

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA)

TIPRANKS
·
Apr 29

Janux Therapeutics Adjusts Board Class Structure for Director

TIPRANKS
·
Apr 29